Jaguar Health (JAGX) Treasury Shares (2014 - 2026)
Jaguar Health (JAGX) posted quarterly Treasury Shares of $1.2 million for Q1 2026, up 1254372.73% year-over-year from N/an in Q1 2025, and up 24639.6% quarter-over-quarter from $5020.0 in Q4 2025.
Jaguar Health (JAGX) Treasury Shares (2014 - 2026) Analysis & Trends
Jaguar Health (JAGX) has reported Treasury Shares for 13 consecutive years, with $1.2 million the latest figure, recorded in Q1 2026.
- In Q1 2026, Treasury Shares rose 1254372.73% year-over-year to $1.2 million; the TTM figure through Mar 2026 stood at $1.2 million (up 1254372.73% YoY), while the FY2025 annual figure was $5020.0, up 4970.71% from the prior year.
- Treasury Shares advanced to $1.2 million in Q1 2026 per JAGX's latest filing, from $5020.0 in the prior quarter.
- Across five years, Treasury Shares topped out at $3.5 million in Q1 2022 and bottomed at $6.0 in Q4 2024.
- Historically, Treasury Shares has averaged $682705.8 across 5 years, with a median of $8408.0 in 2025.
- Annual changes were most pronounced in 2024 — Treasury Shares plunged 99.79% — and 2026, when it surged 1254372.73%.
- Jaguar Health's Treasury Shares stood at $22.0 in 2022, then soared by 8072.73% to $1798.0 in 2023, then slumped by 99.67% to $6.0 in 2024, then jumped by 83566.67% to $5020.0 in 2025, then soared by 24639.6% to $1.2 million in 2026.
- Business Quant data shows JAGX's Treasury Shares at $1.2 million in Q1 2026, $5020.0 in Q4 2025, and $8408.0 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Treasury Shares (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn | - |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn | 36.40 Mn |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn | - |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn | - |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn | - |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn | - |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn | 8.96 Mn |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn | - |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - | 2.72 Mn |
| 10 | Jaguar Health | 447,549.24 | -9.62 Mn | 19.11 Mn | 1.24 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 1.24 Mn |
| Mar 31, 2026 | 1.24 Mn |
| Dec 31, 2025 | 5,020.00 |
| Dec 31, 2025 | 5,020.00 |
| Sep 30, 2025 | 8,408.00 |
| Sep 30, 2025 | 8,408.00 |
| Jun 30, 2025 | 10,434.00 |
| Jun 30, 2025 | 10,434.00 |
| Mar 31, 2025 | 99.00 |
| Mar 31, 2025 | 99.00 |
| Dec 31, 2024 | 6.00 |
| Dec 31, 2024 | 6.00 |
| Sep 30, 2024 | 99.00 |
| Sep 30, 2024 | 99.00 |
| Jun 30, 2024 | 99.00 |
| Jun 30, 2024 | 99.00 |
| Mar 31, 2024 | 99.00 |
| Mar 31, 2024 | 99.00 |
| Dec 31, 2023 | 1,798.00 |
| Dec 31, 2023 | 1,798.00 |